证券记录 · 已归档季度
ALHC
Alignment Healthcare, Inc. · Healthcare · Medical - Healthcare Plans
20被追踪持有人
+1Δ持有人
84.25M持有股份
$1.47B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +5.3% ·
股份流向 +12.2% ·
净新建仓位 0.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | -4 | 153.25M | $3.65B | +8 | −12 |
| Q1 2026 | 111 | +15 | 140.61M | $2.43B | +19 | −5 |
| Q4 2025 | 96 | +1 | 127.62M | $2.52B | +2 | n/a |
| Q3 2025 | 20 | +1 | 84.25M | $1.47B | +1 | −1 |
| Q2 2025 | 17 | 0 | 71.35M | $998.91M | +1 | −1 |
| Q1 2025 | 14 | 0 | 21.82M | $406.29M | +2 | −2 |
| Q4 2024 | 14 | +3 | 25.36M | $285.33M | +3 | n/a |
| Q3 2024 | 10 | +1 | 10.84M | $128.16M | +2 | −1 |
| Q2 2024 | 9 | n/a | 12.27M | $95.98M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 13.97M | +5.0% | $243.75M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 13.58M | +9.3% | $236.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 3 | Wellington Management ✦ | 11.09M | +167.3% | $193.52M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 4 | Fidelity (FMR) ✦ | 8.08M | -26.8% | $141.02M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 5 | Citadel Advisors ✦ | 6.17M | -25.9% | $107.58M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 6 | T. Rowe Price ✦ | 5.57M | +154.0% | $97.25M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 5.49M | -11.5% | $95.83M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 3.54M | +23.7% | $61.82M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | State Street Global Advisors ✦ (被动) | 3.21M | +20.5% | $55.99M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 2.97M | +19.0% | $51.87M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 2.83M | +42.3% | $49.30M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 1.98M | n/a | $34.52M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 13 | Arrowstreet Capital ✦ | 1.61M | +111.8% | $28.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 988.05K | 新增 | $17.24M | 0.0% | New | 1 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 899.27K | n/a | $15.69M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 16 | Goldman Sachs Group ✦ | 895.14K | n/a | $15.62M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | AQR Capital Management ✦ | 755.00K | +154.5% | $13.17M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 18 | D. E. Shaw & Co. ✦ | 316.66K | +144.4% | $5.53M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 19 | Adage Capital Partners ✦ | 283.87K | -36.8% | $4.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Marshall Wace ✦ | 31.00K | -98.5% | $540,862 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Two Sigma Investments | $17.24M | 0.0% |
已清仓
| Norges Bank | $475,748 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 290 持有人, 201.46M 股份, $3.20B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 06
Kim Hyong
Officer · 32.48K 股 · $269,576
Sep 17
KONOWIECKI JOSEPH S
Officer, Director · 23.51K 股 · $202,430
Sep 14
KAO JOHN E
Officer, Director · 27.40K 股 · $356,200
Sep 11
Maroney Dawn Christine
Officer · 122.71K 股 · $1.56M
Sep 11
KAO JOHN E
Officer, Director · 385.27K 股 · $4.89M
Sep 10
KAO JOHN E
Officer, Director · 172.60K 股 · $2.24M
Aug 14
Maroney Dawn Christine
Officer · 5.00K 股 · $70,000
Aug 10
KAO JOHN E
Officer, Director · 298.00K 股 · $4.14M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 05
SC 13G/A: BlackRock, Inc.
Aug 13
SC 13G: Invesco Ltd.
Jul 31
SC 13G: VANGUARD PORTFOLIO MANAGEMENT LLC
Jul 27
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据